Treatment of tardive dyskinesia with pyridoxal 5'-phosphate

Details Treatment of tardive dyskinesia with pyridoxal 5'-phosphate Treatment of tardive dyskinesia with pyridoxal 5'-phosphate

A - Human Necessities

61

K

A61K 31/675 (2006.01) A61P 25/14 (2006.01)

Patent

CA 2590603

This invention relates to treatment of Tardive Dyskinesia through the administration of pyridoxal 5'-phosphate. The treatment may be an oral administration of 100 - 4000 mg/day, for example, 100-750 mg/day or about 250 mg/day. Also provided is the use of pyridoxal 5'-phosphate for the preparation of a medicament for the treatment of tardive dyskinesia, kits comprising pyridoxal 5'-phosphate for the treatment of tardive dyskinesia, and combination drugs for the treatment of tardive dyskinesia.

Affiliated with

Also associated with

Rating

Treatment of tardive dyskinesia with pyridoxal 5'-phosphate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of tardive dyskinesia with pyridoxal 5'-phosphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tardive dyskinesia with pyridoxal 5'-phosphate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1748253